Distal vs. Forearm Radial Artery Access (DRAvsFRA)

June 4, 2023 updated by: Yunis Daralammouri, An-Najah National University

Distal Radial Artery Access in Comparison to Forearm Radial Artery Access for Cardiac Catheterization, a Randomized Controlled Trial

The Distal Radial Access (DRA) to the coronaries has emerged recently. It's done via the distal radial artery in the radial fossa, which is known as the snuff-box. The rationale of conducting this research is to assess this new access advantages and disadvantages, in comparison with the standard conventional forearm radial access and examine if it's worthy to be a future alternative method for coronary angiography. It aims to randomly compare between the new distal radial access via the snuffbox and the conventional forearm radial access for percutaneous coronary angiography and angioplasty procedures. The objectives of comparing both procedures are to analyze the frequency of complications in terms of occlusion, arterial spasm, hematoma, and to weigh accesses effectiveness in terms of time and attempts to puncture, crossover rate, procedure duration, hemostasis time, and convenience of the patients and operators.

Candidates for coronary angiography are being randomized into the interventional group to undergo the angiography through the distal radial artery as the access site, or the control group accessing through the radial artery in the forearm. Procedural and post procedural outcomes and complications are being reported while patients are in hospital. All patients undergo doppler ultrasonography within 24 hours after the procedure.

Study Overview

Study Type

Interventional

Enrollment (Actual)

212

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

14 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Patients who agree to participate in the study and sign the consent form.
  • Patients with an indication for coronary catheterization
  • Clinically stable patients
  • Patients with palpable pulses on both access sites of the radial artery.

Exclusion Criteria:

  • Patients with STEMI
  • Patients with radial AV shunt for hemodialysis
  • Patients with previous CABG using radial artery
  • Patients with previous CABG using LIMA, RIMA or both.
  • Patients with Renaud phenomenon or lymphedema

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Distal Radial
Patients who undergo coronary catheterization by accessing the distal radial artery in the snuff-box of the hand.

The patient grasps his thumb towards the palm to bring the radial artery up to the surface. The left hand is set on the right side of the groin toward the operator, who stands on the right side, with the dorsal surface of hand upwards.

Afterward, the access site is disinfected, lidocaine HCL is SC injected for local anesthesia. Subsequently, the distal radial artery is palpated to find the point of the strongest pulse. Later, at a 45-degree angle, the artery is punctured with a 21-gauge needle and a 0.018 soft, flexible, metallic wire is then inserted in the needle. Through the sheath, 200 micrograms of Nitroglycerin is given. A 5000 unit of unfractionated heparin is administered through the IV line. A weight-adjusted dose of heparin is further added if PCI is needed. Then, a 0.035 wire is introduced in the sheath with other required instruments such as the intracoronary device and the catheters. After pulling out the sheath, a compression device, Safe Guard, is used for hemostasis.

Active Comparator: Forearm Radial
Patients who undergo conventional coronary catheterization by accessing the forearm radial artery.

The right hand is set in the anatomical position, with the anterior surface of arm face upwards.

Afterward, the access site is disinfected, lidocaine HCL is SC injected for local anesthesia. Subsequently, the forearm radial artery is palpated to find the point of the strongest pulse. Later, at a 45-degree angle, the artery is punctured with a 21-gauge needle and a 0.018 soft, flexible, metallic wire is then inserted in the needle. Through the sheath, 200 micrograms of Nitroglycerin is given. A 5000 unit of unfractionated heparin is administered through the IV line. A weight-adjusted dose of heparin is further added if PCI is needed. Then, a 0.035 wire is introduced in the sheath with other required instruments such as the intracoronary device and the catheters. After pulling out the sheath, a compression device, TR band, is used for hemostasis.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Radial artery occlusion
Time Frame: Within 24 hours after the procedure.
Doppler Ultrasonography of the radial artery for occlusions along its course, in both groups.
Within 24 hours after the procedure.

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Ischemic changes to the hand
Time Frame: Within 24 hours after the procedure
It is noted by clinical features of pallor, absence of pulse, pain, cold, paresthesia or paralysis.
Within 24 hours after the procedure
Post-procedural pain
Time Frame: Within 24 hours after the procedure
Assessed by numerical rating scale (NRS) for pain, which is an 11 point subjective scale (0-10) where 0 refers for no pain, 1-3 for mild pain, 4-6 for moderate pain and 7-10 for severe pain.
Within 24 hours after the procedure
Puncture Time
Time Frame: During the procedure
Which is time from first attempt to puncture to the successful one in seconds
During the procedure
Puncture Attempts
Time Frame: During the procedure
Which is the number of puncture attempts from first one until the successful one (maximum 6)
During the procedure
Procedure Duration
Time Frame: During the procedure
In minutes from the insertion of the sheath to its exertion.
During the procedure
Radiation Duration
Time Frame: During the procedure
Which is measured by the radiological device in minutes.
During the procedure
Radiology Dose
Time Frame: During the procedure
Which is measured by the radiological device in mGy.
During the procedure
Compression "hemostasis" time
Time Frame: Up to 240 minutes after band placement
The time from the placement of the compression band until its removal (when there's no blood oozing after deflation), measured by minutes.
Up to 240 minutes after band placement
Arterial spasm
Time Frame: During the procedure

Which is assessed by the operator if present or absent in terms of the difficulty in inserting the wire at the time of the procedures.

of the procedure.

During the procedure
Hematoma and bleeding complications
Time Frame: Within 24 hours after the procedure
It is defined by EASY hematoma scale.
Within 24 hours after the procedure
Crossover (failure to puncture)
Time Frame: During the procedure
It is transforming from the selected access to another after 6 failed attempts to puncture the first selected access
During the procedure
Rare complications
Time Frame: Within 24 hours after the procedure
Pseudo-aneurysm, AV fistula formation, radial artery dissection, which are assessed by Doppler US. In addition to radial artery eversion or perforation.
Within 24 hours after the procedure
Radial Artery Occlusion on follow up
Time Frame: After 2 weeks of the procedure.
Follow up Doppler Ultrasonography for patients with occluded radial artery within 24 hours.
After 2 weeks of the procedure.
Procedural pain
Time Frame: During the procedure
Assessed by numerical rating scale (NRS) for pain, which is an 10 point subjective scale (0-10) where 0 refers for no pain, 1-3 for mild pain, 4-6 for moderate pain and 7-10 for severe pain.
During the procedure

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Yunis Daralammouri, asst. prof., An-Najah National University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

December 1, 2019

Primary Completion (Actual)

December 21, 2020

Study Completion (Actual)

December 21, 2020

Study Registration Dates

First Submitted

September 29, 2019

First Submitted That Met QC Criteria

October 11, 2019

First Posted (Actual)

October 14, 2019

Study Record Updates

Last Update Posted (Actual)

June 6, 2023

Last Update Submitted That Met QC Criteria

June 4, 2023

Last Verified

June 1, 2023

More Information

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Myocardial Infarction

Clinical Trials on distal radial artery access in coronary angiography and angioplasty

Subscribe